Pharmaco - Press Releases

Date	Title	Company
03-Jan-2022	Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA	RELIEF THERAPEUTICS Holding AG
31-Dec-2021	PAION SUBMITS EXTENSION APPLICATION OF MARKETING AUTHORIZATION FOR REMIMAZOLAM IN THE INDICATION GENERAL ANESTHESIA TO THE EUROPEAN MEDICINES AGENCY	PAION AG
30-Dec-2021	Polyphor closes merger with EnBiotix and is renamed Spexis	Polyphor AG
30-Dec-2021	Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change	Cosmo Pharmaceuticals N.V.
30-Dec-2021	Relief Reports U.S. Collab. Partner Announces Filing Breakthrough Therapy Request for Aviptadil in Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies	RELIEF THERAPEUTICS Holding AG
29-Dec-2021	Polyphor to inform about the financing of its merger partner EnBiotix	Polyphor AG
28-Dec-2021	Relief Reports Successful Conclusion of Patent Examination Procedure for Patent Application Entitled, 'Vasoactive Intestinal Peptide (VIP) for the Use in the Treatment of Drug-induced Pneumonitis'	RELIEF THERAPEUTICS Holding AG
27-Dec-2021	Evolva secures additional financing lines to accelerate its growth	Evolva Holding SA
24-Dec-2021	Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in studies from Oxford and Washington Universities	AstraZeneca
24-Dec-2021	Share Dealing and Exercise of Options	Spectral MD Holdings, Ltd.
23-Dec-2021	Demand for MedTech higher than ever as mental health services remain in crisis	Flow Neuroscience
23-Dec-2021	The Medical Products Agency in Sweden will be reference member state for Moberg Pharma’s European registration application	Moberg Pharma AB
23-Dec-2021	Oncorena Secures Financing of the Company’s Continued Development of Orellanine, a Potential Breakthrough Therapy for Advanced Renal Cancer	Oncorena
23-Dec-2021	Creative Diagnostics Launches Immunohistochemistry Antibodies for Pathology Study	Creative Diagnostics
22-Dec-2021	Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Contract for €3 million	Biophytis
22-Dec-2021	ViiV Healthcare announces US FDA approval of Apretude (cabotegravir extended-release injectable suspension), the first and only long-acting injectable option for HIV prevention	ViiV Healthcare
22-Dec-2021	National Institute for Health and Care Excellence Backs Darzalex®▼ (daratumumab) in Combination with Velcade® (bortezomib), Thalidomide and Dexamethasone (DVTd) for Patients with Newly Diagnosed Multiple Myeloma	Janssen Pharmaceutical Companies of Johnson & Johnson
22-Dec-2021	EXACT Therapeutics AS Announces Allowance of Patent Application in Europe for Acoustic Cluster Therapy (ACT®)	EXACT Therapeutics AS
22-Dec-2021	Arix Bioscience co-leads $31 million Series A financing for new portfolio company Sorriso Pharmaceuticals	Arix Bioscience
22-Dec-2021	Gyroscope Therapeutics to be acquired for up to $1.5 billion	Gyroscope Therapeutics